【數據分析】《MultiPlan: MPLN》以1.6億美元收購醫療數據分析AI《Benefits Science》
▌文章出處
▌原文標題
▌Twitter
▌文章序號
Copyright
©2023 智醫科學 MEDai.tw
All rights reserved.
The content of
this site is intended for healthcare and medical professionals.
【數據分析】《MultiPlan: MPLN》以1.6億美元收購醫療數據分析AI《Benefits Science》
▌文章出處
▌原文標題
▌Twitter
▌文章序號
Copyright
©2023 智醫科學 MEDai.tw
All rights reserved.
The content of
this site is intended for healthcare and medical professionals.
【臨床試驗】七家頂尖製藥公司採用《PhaseV》臨床試驗優化機器學習進行藥物開發#臨床試驗 #新藥
— 智醫科學 (@aimedadviser) November 26, 2024
Seven Top Pharma Companies Adopt PhaseV's Machine Learning Technology for Drug Development https://t.co/9mZbKERUlu